Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AKL3
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016462 | pyrophosphatase activity | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 12 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 12 |
GO:0016887 | ATP hydrolysis activity | 7 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.371 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.612 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.601 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.296 |
CLV_PCSK_PC1ET2_1 | 68 | 70 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 226 | 230 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.296 |
DEG_Nend_UBRbox_1 | 1 | 3 | PF02207 | 0.461 |
DEG_SCF_FBW7_1 | 135 | 140 | PF00400 | 0.388 |
DOC_CKS1_1 | 134 | 139 | PF01111 | 0.458 |
DOC_CYCLIN_RxL_1 | 223 | 233 | PF00134 | 0.315 |
DOC_CYCLIN_RxL_1 | 63 | 73 | PF00134 | 0.375 |
DOC_MAPK_DCC_7 | 99 | 108 | PF00069 | 0.296 |
DOC_MAPK_gen_1 | 224 | 231 | PF00069 | 0.315 |
DOC_MAPK_gen_1 | 305 | 312 | PF00069 | 0.550 |
DOC_MAPK_MEF2A_6 | 145 | 153 | PF00069 | 0.316 |
DOC_MAPK_MEF2A_6 | 76 | 83 | PF00069 | 0.315 |
DOC_MAPK_MEF2A_6 | 99 | 108 | PF00069 | 0.296 |
DOC_PP2B_LxvP_1 | 252 | 255 | PF13499 | 0.540 |
DOC_PP2B_LxvP_1 | 310 | 313 | PF13499 | 0.545 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.401 |
DOC_USP7_MATH_1 | 287 | 291 | PF00917 | 0.584 |
DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.371 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.579 |
LIG_14-3-3_CanoR_1 | 43 | 51 | PF00244 | 0.371 |
LIG_14-3-3_CanoR_1 | 69 | 75 | PF00244 | 0.371 |
LIG_APCC_ABBA_1 | 102 | 107 | PF00400 | 0.315 |
LIG_APCC_ABBA_1 | 34 | 39 | PF00400 | 0.315 |
LIG_BRCT_BRCA1_1 | 298 | 302 | PF00533 | 0.437 |
LIG_Clathr_ClatBox_1 | 228 | 232 | PF01394 | 0.339 |
LIG_Clathr_ClatBox_1 | 50 | 54 | PF01394 | 0.296 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.666 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.296 |
LIG_LIR_Apic_2 | 132 | 137 | PF02991 | 0.300 |
LIG_LIR_Gen_1 | 143 | 153 | PF02991 | 0.293 |
LIG_LIR_Gen_1 | 195 | 205 | PF02991 | 0.294 |
LIG_LIR_Gen_1 | 225 | 235 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 306 | 316 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 195 | 201 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 204 | 208 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 225 | 230 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 306 | 312 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 73 | 77 | PF02991 | 0.373 |
LIG_PCNA_yPIPBox_3 | 86 | 99 | PF02747 | 0.458 |
LIG_Pex14_2 | 146 | 150 | PF04695 | 0.269 |
LIG_Pex14_2 | 205 | 209 | PF04695 | 0.296 |
LIG_SH2_GRB2like | 218 | 221 | PF00017 | 0.458 |
LIG_SH2_NCK_1 | 198 | 202 | PF00017 | 0.315 |
LIG_SH2_SRC | 218 | 221 | PF00017 | 0.458 |
LIG_SH2_SRC | 309 | 312 | PF00017 | 0.471 |
LIG_SH2_STAP1 | 198 | 202 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 309 | 312 | PF00017 | 0.406 |
LIG_SH3_3 | 168 | 174 | PF00018 | 0.339 |
LIG_SH3_3 | 211 | 217 | PF00018 | 0.371 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.427 |
LIG_SH3_3 | 310 | 316 | PF00018 | 0.536 |
LIG_SUMO_SIM_anti_2 | 46 | 52 | PF11976 | 0.316 |
LIG_SUMO_SIM_par_1 | 227 | 233 | PF11976 | 0.339 |
LIG_SUMO_SIM_par_1 | 78 | 85 | PF11976 | 0.315 |
LIG_TRAF2_1 | 4 | 7 | PF00917 | 0.682 |
LIG_UBA3_1 | 114 | 119 | PF00899 | 0.353 |
LIG_UBA3_1 | 149 | 155 | PF00899 | 0.371 |
LIG_UBA3_1 | 301 | 307 | PF00899 | 0.447 |
LIG_WRC_WIRS_1 | 71 | 76 | PF05994 | 0.414 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.337 |
MOD_CK2_1 | 1 | 7 | PF00069 | 0.696 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.377 |
MOD_CK2_1 | 271 | 277 | PF00069 | 0.588 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.306 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.604 |
MOD_GlcNHglycan | 288 | 292 | PF01048 | 0.486 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.325 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.338 |
MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.652 |
MOD_N-GLC_1 | 141 | 146 | PF02516 | 0.414 |
MOD_N-GLC_1 | 20 | 25 | PF02516 | 0.709 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.371 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.414 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.564 |
MOD_Plk_1 | 287 | 293 | PF00069 | 0.505 |
MOD_Plk_2-3 | 271 | 277 | PF00069 | 0.648 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.296 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.303 |
MOD_Plk_4 | 230 | 236 | PF00069 | 0.364 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.414 |
MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.371 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.575 |
MOD_SUMO_for_1 | 255 | 258 | PF00179 | 0.629 |
MOD_SUMO_rev_2 | 219 | 225 | PF00179 | 0.407 |
TRG_DiLeu_BaLyEn_6 | 122 | 127 | PF01217 | 0.409 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 198 | 201 | PF00928 | 0.189 |
TRG_ENDOCYTIC_2 | 309 | 312 | PF00928 | 0.510 |
TRG_ER_diArg_1 | 26 | 28 | PF00400 | 0.685 |
TRG_NES_CRM1_1 | 293 | 308 | PF08389 | 0.488 |
TRG_NES_CRM1_1 | 49 | 60 | PF08389 | 0.296 |
TRG_Pf-PMV_PEXEL_1 | 125 | 130 | PF00026 | 0.409 |
TRG_Pf-PMV_PEXEL_1 | 43 | 47 | PF00026 | 0.371 |
TRG_Pf-PMV_PEXEL_1 | 87 | 91 | PF00026 | 0.388 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P494 | Leptomonas seymouri | 80% | 68% |
A0A0S4J9H9 | Bodo saltans | 52% | 73% |
A0A1X0NK74 | Trypanosomatidae | 62% | 68% |
A0A1X0NN10 | Trypanosomatidae | 28% | 71% |
A0A3R7K771 | Trypanosoma rangeli | 59% | 68% |
A0A3R7L848 | Trypanosoma rangeli | 26% | 72% |
A0A3S5H5L6 | Leishmania donovani | 96% | 68% |
A4H4F1 | Leishmania braziliensis | 91% | 100% |
A4HSM8 | Leishmania infantum | 97% | 68% |
C9ZU69 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 66% |
E9AKL2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 100% | 100% |
O42895 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 71% |
P46441 | Haematobia irritans | 37% | 70% |
P64612 | Escherichia coli (strain K12) | 29% | 86% |
P64613 | Escherichia coli O157:H7 | 29% | 86% |
Q32PX9 | Rattus norvegicus | 34% | 68% |
Q3V384 | Mus musculus | 34% | 68% |
Q4QJ96 | Leishmania major | 96% | 100% |
Q8WV93 | Homo sapiens | 34% | 67% |